‘What a mess’: How biotech startups grappled with SVB’s collapse
Bio Pharma Dive
MARCH 13, 2023
The bank’s failure caused some companies to question whether they could pay employees, while forcing many others to take steps to calm nervous investors
Mon.Mar 13, 2023
266 
US FDA approves Acadia Pharmaceuticals’ Rett syndrome therapy
Pharmaceutical Technology
MARCH 13, 2023
The US Food and Drug Administration (FDA) has granted approval for Acadia Pharmaceuticals ’ Daybue (trofinetide) to treat Rett syndrome in adult and paediatric patients aged two years and above.
Join 15,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Clinical trial researchers are burned out too. Automated data capture is helping.
Bio Pharma Dive
MARCH 13, 2023
Manual data transcription increases clinical research coordinator burnout. There is a better way
What Do Patients Have to Say about Gene Therapy Trials? An Upcoming FDA Public Meeting to Hear from Patients and Caregivers
FDA Law Blog
MARCH 13, 2023
By Larry J. Bauer, Senior Regulatory Drug Expert & James E. Valentine — Incorporating patient and caregiver experiences into every phase of drug development has become increasingly prioritized during both development and review ( see, e.g. , previous coverage here ).
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
This webinar will go over the FDA's guidance on pharmacological and toxicological considerations for optimizing doses for prescription drugs.
Pfizer to buy Seagen in $43B cancer drug deal
Bio Pharma Dive
MARCH 13, 2023
The acquisition would give Pfizer control of a top-selling lymphoma drug and a pipeline of medicines that have made the Seattle-based company one of the sector’s most valuable biotechs
Cytovance Biologics and Phenotypeca partner for biopharmaceutical manufacturing
Pharmaceutical Technology
MARCH 13, 2023
Cytovance Biologics has entered a collaboration deal with Phenotypeca to enhance the development of saccharomyces cerevisiae strain for biopharmaceutical manufacturing.
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
Sanofi signs deal to buy Provention Bio for $2.9bn
Pharmaceutical Technology
MARCH 13, 2023
Sanofi has signed an agreement to buy US-based biopharmaceutical firm Provention Bio in a deal valued at nearly $2.9bn. Under the deal, the company will start a cash tender offer to buy Provention Bio’s all outstanding shares for $25.00 per share in cash.
Regulators backstop SVB deposits, offer emergency lending
Bio Pharma Dive
MARCH 13, 2023
SVB’s demise on Friday marked the nation’s largest bank failure since Washington Mutual collapsed in 2008, and sent shock waves through both the life sciences and tech sectors
IIH headaches could be treated with exenatide
Pharma Times
MARCH 13, 2023
The type 2 diabetes therapy is being tested on patients in a phase 2 clinical trial
Sanofi acquires diabetes drug via Provention buyout
Bio Pharma Dive
MARCH 13, 2023
The deal builds on a licensing agreement between Sanofi and Provention to market the first-of-its-kind treatment, called Tzield and approved to slow the disease’s progression
2022 Research: The Rapid Rise of Ocean Freight Visibility
Advertiser: FourKites
Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.
Vygon monitors provide improvement for ovarian cancer patients
Pharma Times
MARCH 13, 2023
Norfolk and Norwich University Hospitals have been using two Mostcare Up devices since 2019
Advancing ‘Smart Pharma’ Capabilities in 2023 and Beyond
Pharmaceutical Commerce
MARCH 13, 2023
Q&A explores new opportunities to strengthen supply chain resilience—and build on the lessons learned.
With $43B buyout, Pfizer sees cancer specialist Seagen as a 'goose' laying 'golden eggs'
Fierce Pharma
MARCH 13, 2023
With $43B buyout, Pfizer sees cancer specialist Seagen as a 'goose' laying 'golden eggs' kdunleavy Mon, 03/13/2023 - 10:16
Novartis Explores Sale of Certain Ophthalmology Assets
BioSpace
MARCH 13, 2023
Novartis Explores Sale of Certain Ophthalmology Assets 3/14/2023
An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space
Speaker: Steve Goldstein, Sales Leader
Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.
Acadia's Daybue wins FDA nod as first treatment for Rett syndrome
Fierce Pharma
MARCH 13, 2023
Acadia's Daybue wins FDA nod as first treatment for Rett syndrome esagonowsky Mon, 03/13/2023 - 09:28
Keytruda Unlocked: How Should Merck Proceed with Trials?
BioSpace
MARCH 13, 2023
Keytruda Unlocked: How Should Merck Proceed with Trials? 3/14/2023
Sanofi throws down $2.9B to acquire diabetes partner Provention Bio
Fierce Pharma
MARCH 13, 2023
Sanofi throws down $2.9B to acquire diabetes partner Provention Bio fkansteiner Mon, 03/13/2023 - 09:05
Exploring AI-based Digital Pathology
Roots Analysis
MARCH 13, 2023
How is AI being used in Digital Pathology? Digital pathology is a transformative technology that has enabled pathologists to make the shift from visual inspection of tissue samples to automated image analysis.
Mandatory COVID Vaccination Policy Template
Advertiser: Aggregage
The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.
Seeking to boost shareholder returns, Novartis readies new $11B buyback round
Fierce Pharma
MARCH 13, 2023
Seeking to boost shareholder returns, Novartis readies new $11B buyback round aliu Mon, 03/13/2023 - 11:07
Why Clinical Trial Diversity Is Important
My Local Study
MARCH 13, 2023
Clinical trial diversity is important because, historically, minority populations have been underrepresented in clinical trial participation. There are several reasons why this has happened. These reasons include language barriers, lack of awareness and trust, and fear of cost and health insurance.
New patent expiration for Becton Dickinson drug CHLORAPREP WITH TINT
Drug Patent Watch
MARCH 13, 2023
Annual Drug Patent Expirations for CHLORAPREP+WITH+TINT Chloraprep With Tint is a drug marketed by Becton Dickinson Co and is included in one NDA. It is available from two suppliers.
Analysis: Biotech After SVB's Collapse
BioSpace
MARCH 13, 2023
Analysis: Biotech After SVB's Collapse 3/14/2023
New patent for Eli Lilly drug OLUMIANT
Drug Patent Watch
MARCH 13, 2023
Annual Drug Patent Expirations for OLUMIANT Olumiant is a drug marketed by Eli Lilly And Co and is included in one NDA. It is available from one supplier. There are… The post New patent for Eli Lilly drug OLUMIANT appeared first on DrugPatentWatch - Make Better Decisions. Patent Added
Informa Connect’s Medicaid & Government Pricing Congress
Drug Channels
MARCH 13, 2023
Informa Connect’s Medicaid & Government Pricing Congress May 16-18, 2023 in Washington, DC www.informaconnect.com/medicaid2023 Drug Channels readers save 10% with code 23DRCH10 * Join the life science industry on May 16-18, 2023 in Washington, DC at the Medicaid & Government Pricing Congress to conquer complex Medicaid regulatory guidelines and evolve strategies to contract, report and comply with federal and state healthcare programs.
New patent for Palatin Technologies drug VYLEESI (AUTOINJECTOR)
Drug Patent Watch
MARCH 13, 2023
Annual Drug Patent Expirations for VYLEESI+%28AUTOINJECTOR%29 Vyleesi (autoinjector) is a drug marketed by Palatin Technologies and is included in one NDA. It is available from one supplier.
BioSpace Salary Report: Life Sciences Salaries Grow at Slower Pace than Previ.
BioSpace
MARCH 13, 2023
BioSpace Salary Report: Life Sciences Salaries Grow at Slower Pace than Previ. 3/14/2023
New patent for Bayer Healthcare drug VITRAKVI
Drug Patent Watch
MARCH 13, 2023
Annual Drug Patent Expirations for VITRAKVI Vitrakvi is a drug marketed by Bayer Hlthcare and Bayer Healthcare and is included in two NDAs. It is available from two suppliers. There… The post New patent for Bayer Healthcare drug VITRAKVI appeared first on DrugPatentWatch - Make Better Decisions.
Amplifier Launches to Bring First AMPK Activator for Obesity to Clinic
BioSpace
MARCH 13, 2023
Amplifier Launches to Bring First AMPK Activator for Obesity to Clinic 3/14/2023
Which pharmaceutical companies have the most aerosol dosed drugs?
Drug Patent Watch
MARCH 13, 2023
This chart shows the pharmaceutical companies with the most aerosol dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most aerosol dosed drugs… The post Which pharmaceutical companies have the most aerosol dosed drugs?
INDIA & ASEA PACIFIC POLLUTION
Pharma Tutor
MARCH 13, 2023
INDIA & ASEA PACIFIC POLLUTION admin Tue, 03/14/2023 - 11:55 Pollution, now a days a very common term that we can hear everywhere; it is in schools, colleges, offices, and media like newspapers, and journals in general.
uMotif welcomes new member to board of directors to aid 'ambitious growth plans'
Outsourcing Pharma
MARCH 13, 2023
Life science and healthcare executive, Adam Deutsch, has joined clinical trial technology company, uMotifâs board of directors. Contract Manufacturing & Logistics
Clinical Data Management in Decentralized Clinical Trials: Data Manager Perspective
Cloudbyz
MARCH 13, 2023
Decentralized clinical trials (DCTs) are becoming increasingly popular as they offer many advantages over traditional clinical trials. DCTs can reduce the need for patients to travel long distances, which can result in a larger and more diverse pool of participants.
SVB collapse: As biotechs report exposure to lender, US government moves to guarantee deposits and HSBC buys UK unit
BioPharma Reporter
MARCH 13, 2023
Businesses and individuals that have money deposited with failed US bank Silicon Valley Bank (SVB) will be able to access all their cash from today, said the US government. Markets & Regulations
Let's personalize your content